These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23993463)

  • 1. Exploiting the Burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology.
    Gourlay LJ; Peri C; Ferrer-Navarro M; Conchillo-Solé O; Gori A; Rinchai D; Thomas RJ; Champion OL; Michell SL; Kewcharoenwong C; Nithichanon A; Lassaux P; Perletti L; Longhi R; Lertmemongkolchai G; Titball RW; Daura X; Colombo G; Bolognesi M
    Chem Biol; 2013 Sep; 20(9):1147-56. PubMed ID: 23993463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible vs Rigid Epitope Conformations for Diagnostic- and Vaccine-Oriented Applications: Novel Insights from the Burkholderia pseudomallei BPSL2765 Pal3 Epitope.
    Gori A; Peri C; Quilici G; Nithichanon A; Gaudesi D; Longhi R; Gourlay L; Bolognesi M; Lertmemongkolchai G; Musco G; Colombo G
    ACS Infect Dis; 2016 Mar; 2(3):221-30. PubMed ID: 27623032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK.
    Gourlay LJ; Thomas RJ; Peri C; Conchillo-Solé O; Ferrer-Navarro M; Nithichanon A; Vila J; Daura X; Lertmemongkolchai G; Titball R; Colombo G; Bolognesi M
    FEBS J; 2015 Apr; 282(7):1319-33. PubMed ID: 25645451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structure-based strategy for epitope discovery in Burkholderia pseudomallei OppA antigen.
    Lassaux P; Peri C; Ferrer-Navarro M; Gourlay LJ; Gori A; Conchillo-Solé O; Rinchai D; Lertmemongkolchai G; Longhi R; Daura X; Colombo G; Bolognesi M
    Structure; 2013 Jan; 21(1):167-175. PubMed ID: 23159127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of a B cell antigen from B. pseudomallei.
    Gaudesi D; Peri C; Quilici G; Gori A; Ferrer-Navarro M; Conchillo-Solé O; Thomas R; Nithichanon A; Lertmemongkolchai G; Titball R; Daura X; Colombo G; Musco G
    ACS Chem Biol; 2015 Mar; 10(3):803-12. PubMed ID: 25495888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding epitopes with computers.
    Malito E; Rappuoli R
    Chem Biol; 2013 Oct; 20(10):1205-6. PubMed ID: 24210005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse vaccinology and subtractive genomics-based putative vaccine targets identification for Burkholderia pseudomallei Bp1651.
    Hizbullah ; Nazir Z; Afridi SG; Shah M; Shams S; Khan A
    Microb Pathog; 2018 Dec; 125():219-229. PubMed ID: 30243554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.
    Swetha RG; Sandhya M; Ramaiah S; Anbarasu A
    J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of peptide mimotopes of Burkholderia pseudomallei exopolysaccharide.
    Legutki JB; Nelson M; Titball R; Galloway DR; Mateczun A; Baillie LW
    Vaccine; 2007 Nov; 25(45):7796-805. PubMed ID: 17935838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence- and Structure-Based Immunoreactive Epitope Discovery for Burkholderia pseudomallei Flagellin.
    Nithichanon A; Rinchai D; Gori A; Lassaux P; Peri C; Conchillio-Solé O; Ferrer-Navarro M; Gourlay LJ; Nardini M; Vila J; Daura X; Colombo G; Bolognesi M; Lertmemonkolchai G
    PLoS Negl Trop Dis; 2015; 9(7):e0003917. PubMed ID: 26222657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
    Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei.
    Muruato LA; Tapia D; Hatcher CL; Kalita M; Brett PJ; Gregory AE; Samuel JE; Titball RW; Torres AG
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28903988
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.
    Su YC; Wan KL; Mohamed R; Nathan S
    Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063.
    Gourlay LJ; Peano C; Deantonio C; Perletti L; Pietrelli A; Villa R; Matterazzo E; Lassaux P; Santoro C; Puccio S; Sblattero D; Bolognesi M
    Acta Crystallogr D Biol Crystallogr; 2015 Nov; 71(Pt 11):2227-35. PubMed ID: 26527140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses of selected phagotopes from monoclonal antibodies of Burkholderia pseudomallei.
    Na-ngam N; Kalambaheti T; Ekpo P; Pitaksajjakul P; Jamornthanyawat N; Chantratita N; Sirisinha S; Thamlikitkul V; Chaicumpa W; Yamabhai M; Ramasoota P
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):443-51. PubMed ID: 18564683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing Probes for Immunodiagnostics: Structural Insights into an Epitope Targeting Burkholderia Infections.
    Capelli R; Matterazzo E; Amabili M; Peri C; Gori A; Gagni P; Chiari M; Lertmemongkolchai G; Cretich M; Bolognesi M; Colombo G; Gourlay LJ
    ACS Infect Dis; 2017 Oct; 3(10):736-743. PubMed ID: 28707874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkholderia thailandensis whole cell antigen cross-reacts with B. pseudomallei antibodies from patients with melioidosis in an immunofluorescent assay.
    Puthucheary SD; Anuar AS; Tee TS
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):395-400. PubMed ID: 20578523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis.
    Gilmore G; Barnes J; Ketheesan N; Norton R
    Clin Vaccine Immunol; 2007 Nov; 14(11):1529-31. PubMed ID: 17804613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of Burkholderia pseudomallei serine metalloprotease: identification of serine protease epitope mimics.
    Chan SW; Nathan S
    FEMS Immunol Med Microbiol; 2005 Jan; 43(1):37-44. PubMed ID: 15607634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.